Penetration of moxifloxacin and levofloxacin into cancellous and cortical bone in patients undergoing total hip arthroplasty

被引:37
作者
Metallidis, S. [1 ]
Topsis, D. [2 ]
Nikolaidis, J. [1 ]
Alexiadou, E. [3 ]
Lazaraki, G. [1 ]
Grovaris, L. [2 ]
Theodoridou, A. [1 ]
Nikolaidis, P. [1 ]
机构
[1] AHEPA Univ Hosp, Div Infect Dis, Dept Internal Med 1, Thessaloniki, Greece
[2] Hippokrateion Hosp, Dept Orthoped, Thessaloniki, Greece
[3] Aristotle Univ Thessaloniki, Dept Chem, Thessaloniki, Greece
关键词
moxifloxacin; levofloxacin; osteomyelitis; HPLC; bone penetration;
D O I
10.1179/joc.2007.19.6.682
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Penetration of levofloxacin and moxifloxacin into cancellous and cortical bone was studied using high-performance liquid chromatography (HPLC) in 16 patients who underwent routine total hip arthroplasty. Our results demonstrate a good degree of penetration into bone for both quinolones. The mean cancellous penetration was 53.86% for moxifloxacin and 54.13% for levofloxacin. The penetration into cortical bone was 41.59% and 34.26% respectively. The concentrations for both quinolones were above the minimum inhibitory concentration (MIC90s) for the most common pathogens, so they can be used for the treatment of osteomyelitis.
引用
收藏
页码:682 / 687
页数:6
相关论文
共 21 条
[1]  
[Anonymous], REV INFECT DIS
[2]  
Barrett J F, 2000, Curr Opin Investig Drugs, V1, P45
[3]   Pathophysiology of chronic bacterial osteomyelitis. Why do antibiotics fail so often? [J].
Ciampolini, J ;
Harding, KG .
POSTGRADUATE MEDICAL JOURNAL, 2000, 76 (898) :479-483
[4]   In vitro antibacterial activity and phamacodynamics of new quinolones [J].
Dalhoff, A ;
Schmitz, FJ .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2003, 22 (04) :203-221
[5]  
Eliopoulos G M, 1995, Drugs, V49 Suppl 2, P48
[6]   PHARMACODYNAMICS OF INTRAVENOUS CIPROFLOXACIN IN SERIOUSLY ILL-PATIENTS [J].
FORREST, A ;
NIX, DE ;
BALLOW, CH ;
GOSS, TF ;
BIRMINGHAM, MC ;
SCHENTAG, JJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (05) :1073-1081
[7]   Activity of moxifloxacin and other quinolones against pneumococci resistant to first-line agents, or with high-level ciprofloxacin resistance [J].
Johnson, AP ;
Warner, M ;
Livermore, DM .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2001, 17 (05) :377-381
[8]   Prosthetic joint infections: Bane of orthopedists, challenge for infectious disease specialists [J].
Lentino, JR .
CLINICAL INFECTIOUS DISEASES, 2003, 36 (09) :1157-1161
[9]   Osteomyelitis [J].
Lew, DP ;
Waldvogel, FA .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (14) :999-1007
[10]   Osteomyelitis [J].
Lew, DP ;
Waldvogel, FA .
LANCET, 2004, 364 (9431) :369-379